Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00658892
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00005815
What this trial is testing

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Very early researchStudy completedNCT01425749
What this trial is testing

Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI

Who this might be right for
Melanoma
Craig L Slingluff, Jr 25
Testing effectiveness (Phase 2)Study completedNCT01253096
What this trial is testing

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 25
Testing effectiveness (Phase 2)Study completedNCT00002952
What this trial is testing

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Chicago 20
Early research (Phase 1)Ended earlyNCT00272415
What this trial is testing

Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma

Who this might be right for
Melanoma
Genentech, Inc. 39
Early research (Phase 1)Study completedNCT01103635
What this trial is testing

Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Abramson Cancer Center at Penn Medicine 25
Early research (Phase 1)UnknownNCT00022568
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01672450
What this trial is testing

Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma

Who this might be right for
Melanoma
University of Utah 12
Early research (Phase 1)Study completedNCT00276536
What this trial is testing

Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Breast CancerKidney CancerLymphoma+4 more
The Cleveland Clinic 35
Testing effectiveness (Phase 2)Study completedNCT00612664
What this trial is testing

Phase II, 2nd Line Melanoma - RAND Monotherapy

Who this might be right for
Melanoma
Bristol-Myers Squibb 158
Not applicableEnded earlyNCT02744209
What this trial is testing

Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

Who this might be right for
Stage IV Melanoma
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT00450372
What this trial is testing

Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
University of Miami 38
Testing effectiveness (Phase 2)Study completedNCT01136967
What this trial is testing

An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage IIIStage IV Melanoma
Eisai Inc. 182
Testing effectiveness (Phase 2)WithdrawnNCT01833767
What this trial is testing

Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Western Regional Medical Center
Not applicableTemporarily pausedNCT06391099
What this trial is testing

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more
Ohio State University Comprehensive Cancer Center 60
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT04570332
What this trial is testing

BO-112 With Pembrolizumab in Unresectable Malignant Melanoma

Who this might be right for
Melanoma
Highlight Therapeutics 42
Testing effectiveness (Phase 2)Study completedNCT02523313
What this trial is testing

Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 167
Early research (Phase 1)Active Not RecruitingNCT01590069
What this trial is testing

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 70
Next Page